Full Length Research Paper
References
|
Anderson AS, Miller AA, Donald RG, Scully IL, Nanra JS, Cooper D, Jansen KU (2012). Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Journal of Human vaccines and immunotherapeutics 8:1585-1594. |
|
|
Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, Eick S, Kellermann J, Schmitt M, Potempa J, Magdolen V (2008). The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochemical Journal 410:157-165. |
|
|
Bendary MM, Solyman SM, Azab MM, Mahmoud NF, Hanora AM (2016). Characterization of Methicillin Resistant Staphylococcus aureus isolated from human and animal samples in Egypt. Journal of Cellular and Molecular Biology 62:94-100. |
|
|
Bruno L, Cortese M, Rappuoli R, Merola M (2015). Lessons from Reverse Vaccinology for viral vaccine design. Journal of Current Opinions Virololgy 11:89-97. |
|
|
Carter NJ (2013). Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero®): a review of its use in primary and booster vaccination (2013). Journal of BioDrugs 27:263-274. |
|
|
Chen C, Yan Q, Tao M, Shi H Han, X, Jia L, Huang Y, Zhao L, Wang C, Ma X, Ma Y (2019). Characterization of serine acetyltransferase (CysE) from methicillin-resistant Staphylococcus aureus and inhibitory effect of two natural products on CysE. Journal of Microbial pathogenesis 131(1):218-26. |
|
|
Chong YP, Park KH, Kim ES, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS (2015). Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia. Journal of Antimicrobial agents and chemotherapy 59:3541-3547. |
|
|
Das A, Biswas M (2019). Cloning, overexpression and purification of a novel two-domain protein of Staphylococcus aureus phage Phi11. Journal of Protein expression and purification 1(154):104-111. |
|
|
Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D (2015). Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Journal of Human vaccines & immunotherapeutics 116:32-41. |
|
|
Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, Corey GR, Carmeli Y, Betts R, Hartzel J, Chan I, McNeely T, Kartsonis NA, Guris D, Onorato MT, Smugar SS, DiNubile MJ, Meulen AS (2013). Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA The Journal of the American Medical Association 309(13):1368-1378. |
|
|
Harik NS, Com G, Tang X, Castro MM, Stemper ME, Carroll JL (2016). Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence. American journal of infection control 44(4):409-415. |
|
|
He F (2011). Laemmli-SDS-PAGE. Bio-protocol Bio101:e80. |
|
|
Heinson AI, Woelk CH, Newell M-L (2015). The promise of reverse vaccinology. Journal of International health 7:85-89. |
|
|
Kimple ME, Brill AL, Pasker RL (2013). Overview of affinity tags for protein purification. Current protocols in protein science 73(1):9-17. |
|
|
Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, Fu Y, French SW, Edwards JE, Spellberg B (2009). Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. Journal of PLoS pathogens 5:e1000703. |
|
|
Lloyd SM, Vance GFJr, Sanjay KS, Warren ER, Richard AP (2020). Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS. Journal of Microbiology Reviews 44(1):123-153. |
|
|
Marlieke EA de Kraker, Martin W, Peter GD, Walter K, Jutta B, Jan N, Claudine I, Smilja K, Jasminka H, Harald S, Achim JK, Olga P, Athina A, Maria B, Edmond S, Mairead S, Annibale R, Uga D, Agita MK, Michael B, Deborah X, Mihaela CG, Michelle N, Jana K, Stanko G, David T, Louise L, Hajo G (2011). Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Journal of Antimicrobial Agents and Chemotherapy 55(4):1598-1605. |
|
|
McNeely TB, Shah NA, Fridman A, Joshi A, Hartzel JS, Keshari I, Florea Lupu RS, DiNubile MJ (2014). Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. Journal ofHuman vaccines & immunotherapeutics 10(3):513-516. |
|
|
Nakata Y, Tang X, Yokoyama KK (1997). Preparation of competent cells for high-efficiency plasmid transformation of Escherichia coli. cDNA Library Protocols: Springer pp. 129-137. |
|
|
Naz A, Awan FM, Obaid A, Muhammad SA, Paracha RZ, Ahmad J, Ali J (2015). Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology-based approach. Journal of Infection, Genetics and Evolution 32:280-291. |
|
|
Nickerson NN, Joag V, McGavin MJ (2008). Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved Nâ€terminal fungalysinâ€thermolysinâ€propeptide domain. Journal of Molecular microbiology 69(6):1530-1543. |
|
|
Olaniyi R, Pozzi C, Grimaldi L, Bagnoli F (2017). Staphylococcus aureus-Associated Skin and Soft Tissue Infections: Anatomical Localization, Epidemiology, Therapy and Potential Prophylaxis. Current Topics in Microbiology and Immunology 409:199-227. |
|
|
Proctor RA. (2012). Is there a future for a Staphylococcus aureus vaccine? Vaccine 30:2921-2927. |
|
|
Proctor RA (2015). Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges. Journal of European Cell and Material 30(734):315-326. |
|
|
Rappuoli R (2001). Reverse vaccinology, a genome-based approach to vaccine development. Journal of Vaccine 19:2688-2691. |
|
|
Redi D, Raffaelli CS, Rossetti B, Luca AD, Montagnani F (2018). Staphylococcus aureus vaccine preclinical and clinical development: current state of the art. Journal of New Microbiology 41:208-213. |
|
|
Rupp ME, Holley HP, Lutz J, Dicpinigaitis PV, Christopher W W, Levine DP, Veney N, Fowler VG (2007). Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy 51(12):4249-4254. |
|
|
Salgado-Pabón W, Schlievert PM. Models matter (2014). The search for an effective Staphylococcus aureus vaccine. Journal of Nature Review in Microbiology 12(8):585-591. |
|
|
Seib KL, Zhao X, Rappuoli R (2012). Developing vaccines in the era of genomics: a decade of reverse vaccinology. Journal of Clinical Microbiology and Infection 18:109-116. |
|
|
Soltan MA, Magdy D, Solyman SM, Hanora A (2020). Design of Staphylococcus aureus New Vaccine Candidates with B and T Cell Epitope Mapping, Reverse Vaccinology, and Immunoinformatics. OMICS A Journal of Integrative Biology 24(4):195-204. |
|
|
Stach N, Kaszycki P, WÅ‚adyka B (2018). Extracellular Proteases of Staphylococcus spp. Pet-To-Man Travelling Staphylococci. Elsevier Journal pp. 135-145. |
|
|
Toleman MS, Sandra R, Dorota J, Hayley JW, Beth B, Ewan MH, Francesc C, Russell JH, Angela K, Julian P, Sharon JP, Török ME (2019). Prospective genomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) associated with bloodstream infection, England, 1 October 2012 to 30 September 2013. |
|
|
Van Kessel KP, Bestebroer J, van Strijp JA (2014). Neutrophil-mediated phagocytosis of Staphylococcus aureus. Journal of Frontiers in Immunology 5:467. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
